Quarter Period Consolidated Statement Of Comprehensive Income

Immuno-Biological Laboratories Co., Ltd. - Filing #7244299

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
249,047,000 JPY
249,047,000 JPY
249,047,000 JPY
249,047,000 JPY
249,047,000 JPY
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
Comprehensive income
249,047,000 JPY
186,694,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
249,047,000 JPY
186,694,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.